1 |
American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare- associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
DOI
ScienceOn
|
2 |
Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care associated pneumonia, 2003: recommendations of CDC and the healthcare infection control practices advisory committee. MMWR Recomm Rep 2004;53:1-36.
|
3 |
Edwards JR, Peterson KD, Mu Y, et al. National healthcare safety network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783-805.
DOI
ScienceOn
|
4 |
Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121.
DOI
ScienceOn
|
5 |
Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian critical trials group. Am J Respir Crit Care Med 1999;159:1249-1256.
DOI
ScienceOn
|
6 |
Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributablee cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-1317.
DOI
ScienceOn
|
7 |
Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627-634.
DOI
ScienceOn
|
8 |
Bonten MJ. Controversies on diagnosis and prevention of ventilator associated pneumonia. Diagn Microbiol Infect Dis 1999;34:199-204.
DOI
ScienceOn
|
9 |
Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Cre Trials Group N Engl J Med 1998;338:791-797.
|
10 |
Schuster DP, Rowley H, Feinstein S, McGue MK, Zuckerman GR. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984;76:623-630.
DOI
ScienceOn
|
11 |
Fabian TC, Boucher BA, Croce MA, et al. Pneumonia and stress ulceration in severely injured patients: a prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993;12:185-191.
|
12 |
Ellison RT, Perez-Perez G, Welsh CH, et al. Risk factors for upper gastrointestinal bleeding in intensive care unit patients: role of helicobacter pylori. Federal Hyperimmune Immunoglobulin Therapy Study Group. Crit Care Med 1996;24:1974-1981.
DOI
ScienceOn
|
13 |
Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care 2009;15:139-143.
DOI
ScienceOn
|
14 |
Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5:368-375.
DOI
ScienceOn
|
15 |
Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330:377-381.
DOI
ScienceOn
|
16 |
Lam NP, Le PD, Crawford SY, Patel S. National survey of stress ulcer prophylaxis. Crit Care Med 1999;27:98-103.
DOI
ScienceOn
|
17 |
Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am 2009;38:245-265.
DOI
ScienceOn
|
18 |
Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med 2002;30(6 Suppl):S351-S355.
DOI
|
19 |
Geus WP. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding? Scand J Gastroenterol Suppl 2000:S10-S20.
|
20 |
Welage LS. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm 2005;62(10 Suppl 2):S4-S10.
|
21 |
Spirt MJ. Stress-related mucosal disease. Curr Treat Options Gastroenterol 2003;6:135-145.
DOI
ScienceOn
|
22 |
Khouli H, Shapiro J, Pham VP, et al. Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit. J Intensive Care Med 2006;21:352-358.
DOI
ScienceOn
|
23 |
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):S381-S453.
DOI
|
24 |
Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 2005;33:1565-1571.
DOI
ScienceOn
|
25 |
Crowther MA, Cook DJ, Griffith LE, et al. Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med 2005;31:48-55.
DOI
ScienceOn
|
26 |
Bang SM, Jang MJ, Oh D, et al. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci 2010;25:1553-1559.
DOI
ScienceOn
|
27 |
Limpus A, Chaboyer W, McDonald E, Thaliib L. Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care 2006;15:402-410; discussion 411-412.
|